VLS Tirzepatide Pen

Mechanism of Action (Research Context):

GLP-1 receptor activation: Enhances insulin secretion, inhibits glucagon release, delays gastric emptying, and modulates appetite regulation pathways via CNS signaling.

GIP receptor activation: Potentiates glucose-stimulated insulin release, supports adipocyte function, and may synergize with GLP-1 to influence energy balance and lipid metabolism.

Research Applications:
– Studies of incretin hormone biology and insulin signaling pathways.
– Investigations into obesity, type 2 diabetes, and metabolic syndrome.
– Exploration of central appetite regulation and energy homeostasis.
– Evaluation of receptor binding dynamics, intracellular signaling cascades, and pharmacokinetics in preclinical models.

*For research purposes only